Fidelis Capital Partners’s CVS Health CVS Stock Holding History

Fidelis Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Buy	25,804 +7,160	+38%	+$552K	0.13%	135
2025 Q4	$1.48M	Buy	18,644 +1,913	+11%	+$151K	0.11%	153
2025 Q3	$1.26M	Buy	16,731 +417	+3%	+$28.6K	0.1%	164
2025 Q2	$1.04M	Buy	16,314 +2,628	+19%	+$172K	0.09%	168
2025 Q1	$894K	Buy	13,686 +7,410	+118%	+$443K	0.1%	169
2024 Q4	$351K	Sell	6,276 -1,010	-14%	-$56.7K	0.04%	309
2024 Q3	$414K	Sell	7,286 -11,181	-61%	-$652K	0.05%	264
2024 Q2	$1.04M	Sell	18,467 -4,132	-18%	-$258K	0.15%	132
2024 Q1	$1.8M	Buy	22,599 +4,870	+27%	+$372K	0.27%	73
2023 Q4	$1.4M	Buy	17,729 +6,357	+56%	+$452K	0.31%	68
2023 Q3	$796K	Buy	11,372 +1,585	+16%	+$112K	0.27%	79
2023 Q2	$677K	Buy	9,787 +775	+9%	+$55.1K	0.25%	97
2023 Q1	$637K	Buy	9,012 +5,662	+169%	+$475K	0.27%	94
2022 Q4	$306K	Buy	+3,350	New	+$323K	0.36%	79

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelis Capital Partners's CVS Position: Q1 2026 in Review

Fidelis Capital Partners increased its CVS Health (CVS) stake by 38% in Q1 2026, buying an estimated $552K and bringing the position to 25,804 shares worth $1.85M. The position accounts for 0.13% of the portfolio, ranked #135.

Fidelis Capital Partners first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Fidelis Capital Partners held 25,804 shares of CVS Health worth $1.85M as of Q1 2026.
Fidelis Capital Partners bought 7,160 CVS Health shares in Q1 2026, an estimated $552K.
CVS Health made up 0.13% of Fidelis Capital Partners's portfolio in Q1 2026, its #135 holding.
Fidelis Capital Partners first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.